Navigation Links
Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results
Date:12/4/2008

TUSTIN, Calif., Dec. 4/PRNewswire-FirstCall/ --Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it will release its financial results for the second quarter of fiscal year 2009 on December 10, 2008 at 7:00 a.m. EST and will host a conference call and webcast to discuss the results at 11:30 a.m. EST on the same day.

Peregrine's senior management will discuss financial results for the second quarter ended October 31, 2008 and will review recent operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the archived webcast.

The conference call and webcast will begin at 11:30 a.m. EST/ 8:30 a.m. PST.

To listen to a live broadcast of the call over the Internet or to review the archived webcast, please visit: http://www.peregrineinc.com. The webcast will be archived on Peregrine's website for 30 days.

To listen to the conference call via telephone, please call the following number approximately 10 minutes prior to the scheduled start time and request to join the Peregrine Pharmaceuticals call: (800) 860-2442. A telephonic replay of the conference call will be available starting approximately one hour after the conclusion of the call through December 17, 2008 by calling (877) 344-7529, passcode 382933#.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead produc
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
3. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
4. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
6. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
8. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
9. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... iCardiac now provides ser...cal companies. , Rocheste...ogies, Inc., a global leader in advanced cardiac c...that a top five pharmaceutical company has selecte...ervices. iCardiac will provide Highly Automated Q...
(Date:11/30/2009)..., , COLUMBUS, Ohio, Nov. 30 /PRNewswire/ -...ort for one of the nation,s first minority busines...eld in Cleveland December 3, is called "Transformi...y Business Early-Stage Capital Summit." It will fe...al minority business leaders and local minority en...
(Date:11/30/2009)..., , BLOOMINGTON, Minn., Nov. 30 /PRNewswire...ance medical image management software, data migra...ng with Allina Hospitals and Clinics for a new Ven...n of image storage across the Allina network of ho...ng solution is based on the Acuo Technologies DICO...
(Date:11/30/2009)..., , BRIARCLIFF MANOR, N.Y., Nov. 30 /... a key guidance document for the publication of co...ed online today by the British Medical Journal (BM...gnition of the importance of providing support and...publication of study results in the peer-reviewed ...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3
...affiliate of,Phlo Corporation (Pink Sheets: PHLC) ...ion of its vitality product, AQUISS(TM), in Califo... within Northern California and has,been introduce...with the,Palm Desert/Palm Springs area. In Northe...ndiser,Holiday Meeting, which was instrumental in ...
...se Review with Drs. Morton Kern, Nico ...en and WILMINGTON, Mass., Oct. 19 The use,of frac...utcomes is the,topic of several sessions at this y...mposium, TCT 2007, which will take place Oct. 20-2...st company to develop systems that,calculate FFR w...
...PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals in the rap...hat it intends to release its 2007 third quarter r...ket opens in the United States.,Simcere,s chief ex...,officer, Frank Zhigang Zhao, will host an earning...
Other Biology Technology:AQUISS Continues Expansion Into New Territory 2Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3
(Date:12/1/2009)...S, Ohio Ohio State University cancer researchers ...kills brain-tumor cells and blocks the growth of n...hat viruses designed to kill cancer cells oncolyt...sive brain tumors if they also carry a gene for a ...protein, called vasculostatin, is normally produce...
(Date:12/1/2009)..., NEW YORK, Dec. 1 iQor, a glob...services, was included in the 2009 InfoWorld 100...ic-enabled ERP system, TeQ21. This was the first s...cognized among this prestigious list of companies,...eQ21 is completely transforming the way we do busi...
(Date:12/1/2009)...ess, like a bad cold, can spread among groups of p...University of California-San Diego and Harvard sho...study that has been following health conditions fo...t lonely people tend to share their loneliness wit...disconnected people moves to the fringes of social...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3Amilpar Operating Revenues Grew 9 25 in the Second Quarter and 11 25 in the First Half of 2009 54276 1Amilpar Operating Revenues Grew 9 25 in the Second Quarter and 11 25 in the First Half of 2009 54276 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 1Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 3Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 1Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 2
...ity of North Carolina at Chapel Hill,s newest "lib...book lover, but it eventually will please thousand...ch researchers, work, it will undoubtedly contribu...t depend on every day, its developers say. , Named...oluminous genetic data on 39 plant species. The li...
... not for fun but for fuel. Burning grass for energ...r decades. But not in the United States. , Yet bur...rgy-efficient, environmentally friendly and sustai...t. , This alternative fuel easily could be produc...stoves built to burn wood pellets or corn, says Je...
...ns infectious disease specialists who have spent m... and AIDS worldwide are warning that limited inter...es currently being distributed in Africa, Asia and... afford to pay for them. , In an article appearing...une 28, infectious disease specialist Jonathan Zen...
Other Biology News:Unique library of plant genes germinates, takes root at UNC 2Grass makes environmentally friendly biofuel 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4
Goat Anti-HIV-1 HIV1 p24 Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Human CD11b / Mac-1alpha Monoclonal Antibody, Unconjugated, Clone LM2 / 1 from Cell Sciences
RABBIT (BABY) COMPLEMENT LYOPHILISED from AbD Serotec
Rabbit Anti-Human ZO-1 Antibody, Unconjugated from Lab Vision
Biology Products: